Hedge Fund Manager Proves Evil Exists
The former hedge fund manager who planned to profit by forcing scores of AIDS patients to die agonizing deaths, has back-tracked slightly after Hilary Clinton labeled him a ‘price-gouger’ and public minded activists (seemingly more effectively) published his midtown Manhattan home address (click here for details )
Previously, Martin Shkreli, 32, the CEO of Turing Pharmaceuticals, had brushed off critics who complained about him jacking up the price of life-saving drug Daraprim from $13.50 to $750 per pill, dismissing them as ‘morons’, ‘socialists and liberals’ .
“The price per course of treatment to save your life was only $1000 and we know these days, [with] modern pharmaceuticals, cancer drugs can cost $100,000 or more, rare disease drugs can cost half a million dollars,” he told Bloomberg news.
Speaking next on CNN the shameless profiteer boasted he wouldn’t reduce the new price even if it meant ‘doctors and patient groups are saying they can’t access this drug.”
Following an internet firestorm of criticism, however, he ended the week by dropping the new price to $1,050 for 30 pills (reduced from $22,500 though still considerably more than the previous price of $390.)
“We haven’t gone to his house (yet), but we did call the phone number and it appears to be legitimate,” music website DeathAndTaxes responded following the publication of his address details.
“His mailbox has yet to fill up, dear readers, so feel free to call him and give him some advice about ethics in business. I’m sure he’ll be happy to hear from you.”
Donald Trump also labelled Shkreli a ‘spoiled brat’ and suggested ‘he out to be ashamed of himself’.
“I thought it was a disgusting thing, what he did,” the Republican presidential candidate added. “I thought it was a disgrace.” (Business-Insider: http://bit.ly/1G5TFWx )
http://wapo.st/1NMnWA9 (‘Martin Shkreli, ‘price-gouging’ CEO, bankrolled punk label — and his punk-rock friends now hate him . . .” “We would like to make one thing clear — we would never knowingly work with Martin Shkreli, or anybody willing to walk across the backs of the sick and dying with a smile on their face for the sake of making a profit . . .’)
